Effects of Red Blood Cell Transfusion on Anemia-Related Symptoms in Patients with Cancer
- 1 January 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Palliative Medicine
- Vol. 12 (1), 60-63
- https://doi.org/10.1089/jpm.2008.0139
Abstract
The aim of this study was to assess the effects of red blood cell transfusion, and the subsequent increase in hemoglobin values, on anemia-related symptoms in a cohort of patients with cancer with different survival times. A red blood cell transfusion was recommended to a consecutive sample of patients with hemoglobin levels of 8 ± 0.5 g/dL. The number of units to be ordered was decided according the hemoglobin values with a mean target of increasing the hemoglobin values by approximately 2 g/dL. Hemoglobin values, anemia-related signs and symptoms, including well-being, fatigue, and dyspnea, were recorded at admission (T0), 1 day after the last transfusion (T1), and 15 days afterward (T2) by telephone contact or visit. Well-being, fatigue, and dyspnea were measured on a numerical scale of 0–10. Sixty-one patients were recruited in the period of study. One hundred thirty-three units of red blood cells were transfused (mean 2.18, 95% confidence interval [CI] 0.6). Complete data were available for 40 patients. Hemoglobin values and well-being significantly increased after transfusion (T1), maintaining acceptable values 15 days afterward (T2). Significant changes in fatigue and dyspnea were found immediately after transfusion, although the effect was partially lost 15 days after transfusion. No statistical differences were found between patients with different survival times. Fatigue was significantly lower in patients with longer survival times in comparison with patients with shorter survival times (p = 0.04). Blood transfusion in patients with hemoglobin values of approximately 8 g/dL improved anemia-related symptoms on a short-term basis. This benefit is independent of the stage of disease and survival. However, the effects on dyspnea and fatigue tend to decrease within 15 days, despite the maintenance of hemoglobin values attained after transfusions, suggesting that other factors may play a role.Keywords
This publication has 14 references indexed in Scilit:
- Clinical and financial analysis of an acute palliative care unit in an oncological departmentPalliative Medicine, 2008
- Donepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled TrialJournal of Clinical Oncology, 2007
- Survey of Blood Transfusion Practice for Palliative Care Patients in Yorkshire: Implications for Clinical CareJournal of Palliative Medicine, 2007
- Practice Guidelines for Perioperative Blood Transfusion and Adjuvant TherapiesAnesthesiology, 2006
- The Association between Anemia and Fatigue in Patients with Advanced Cancer Receiving Palliative CareJournal of Palliative Medicine, 2005
- Edmonton symptom assessment scale: Italian validation in two palliative care settingsSupportive Care in Cancer, 2005
- Anaemia in cancer: pathophysiology and treatmentCancer Treatment Reviews, 2000
- Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unitJournal of Pain and Symptom Management, 1996
- Blood transfusion and its benefits in palliative carePalliative Medicine, 1995
- The use of transfusion in terminal cancer patientsTransfusion, 1985